|
Status |
Public on Oct 31, 2012 |
Title |
HeLa treated with Cas-II-gly, biological rep1 |
Sample type |
RNA |
|
|
Source name |
HeLa cells treated with Cas-II-gly
|
Organism |
Homo sapiens |
Characteristics |
cell line: cervical cancer (HeLa) cells agent: Cas II-gly
|
Treatment protocol |
Cells were treated with Cas II-gly in 6-well microplates by 6h. In order to diminish biological variability, pools of 3 wells were made and combined into a single sample before proceeding to chip hybridization.
|
Growth protocol |
HeLa cells were mantained at room temperature in 5% CO2 under sterile conditions in DMEM, Sigma), supplemented with 10% fetal bovine serum (Sigma).
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA isolated using AllPrep DNA-RNA Mini Kit 50.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to Affymetrix, Santa Clara CA Inc. protocol from 400 ng total RNA.
|
|
|
Hybridization protocol |
Hybridization to Affymetrix U133plus2 GeneChips, staining and washing were carried out as described (Affymetrix, Santa Clara).
|
Scan protocol |
Scanning procedure was carried out as described by Affymetrix, Santa Clara.
|
Description |
Gene expression data from HeLa cells treated with Cas-II-gly. Cas_II-gly-1
|
Data processing |
Data pre-processing was performed by using the affy library in BioConductor running under [R].
|
|
|
Submission date |
Oct 24, 2012 |
Last update date |
Oct 31, 2012 |
Contact name |
Karol Baca Lopez |
E-mail(s) |
[email protected]
|
Organization name |
National Institute of Genomic Medicine
|
Street address |
Periferico sur
|
City |
Mexico City |
ZIP/Postal code |
14610 |
Country |
Mexico |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE41827 |
Expression data from HeLa cells treated with Casiopeina Cas-II-gly |
|